Delivery Order SPE2DR25D1002-SPE2DR26FGM0C
- Not listed
- The Defense Logistics Agency awarded a $6,558.42 firm fixed-price delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on December 8, 2025, with completion targeted for December 9, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The work will be performed at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of RINVOQ ER 15 mg tablets (30-count unit dose packaging) with a contract value of $4,960.66. This is a firm fixed-price delivery order with an ultimate completion date of December 9, 2025, and represents a non-competitive, non-set-aside award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of RINVOQ ER 15 mg tablets (30-count units) valued at $12,074.99. This is a firm fixed price, non-set-aside competitive delivery order with an ultimate completion date of November 19, 2025, and performance at the vendor's Conshohocken, Pennsylvania facility. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a $39,149.39 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 29, 2025, for the supply of RINVOQ ER 15 mg tablets (30-count units). This is a non-set-aside, competitively awarded contract with an ultimate completion date of December 30, 2025, and performance to be executed from the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $16,372.33 for RINVOQ ER 15 mg tablets (30-count units) on December 19, 2025, with an ultimate completion date of December 22, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The order will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $3,299.54 delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for RINVOQ ER 15 mg tablets (30-count units). This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order will be fulfilled from the company's corporate office location in...
- The Defense Logistics Agency awarded a $7,430.62 delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of RINVOQ ER 15 mg tablets (30-count unit doses), with a completion date of December 2, 2025. This firm fixed-price, non-set-aside contract will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for RINVOQ ER 15 mg tablets (30-unit bottles) under a firm fixed-price contract valued at $10,362.56. This is a non-set-aside competitive award with an ultimate completion date of July 30, 2025. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical support vehicle...
- The Defense Logistics Agency awarded a delivery order valued at $13,037.95 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on October 23, 2025, with completion scheduled for October 24, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency awarded a $20,993.74 delivery order to AmerisourceBergen Drug Corp on December 23, 2025, for RINVOQ ER 15 mg tablets (30-count units), with completion scheduled for December 24, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed price pricing and is performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- SPE2DR25D1002Indefinite Delivery Contract
- SPE2DR25D1002-SPE2DR26FGM0CDelivery Order
The Defense Logistics Agency awarded a $10,035.14 delivery order to AmerisourceBergen Drug Corp on December 29, 2025, for the supply of RINVOQ ER 15 mg tablets in quantities of 30 units. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of December 30, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains a significant role in federal medical procurement as a critical vendor for military and veteran healthcare systems. The parent IDC enables the company to supply a broad range of pharmaceutical products and medical supplies to support Defense Health Agency operations and other government healthcare systems worldwide. RINVOQ is a specialized rheumatoid arthritis treatment, reflecting the types of specialty medications within AmerisourceBergen's extensive federal contract portfolio. The delivery order structure allows the DLA to procure specific pharmaceutical requirements on an as-needed basis from the established contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.0k | 12/28/25 |